Related references
Note: Only part of the references are listed.Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses
Ryota Tanaka et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
Human Rhinovirus Infection Enhances the Th2 Environment in Allergic and Non-allergic Patients With Chronic Rhinosinusitis
Young-Kyung Ko et al.
CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY (2021)
Role of orally induced regulatory T cells in immunotherapy and tolerance
Thais B. Bertolini et al.
CELLULAR IMMUNOLOGY (2021)
Glucose metabolism involved in PD-L1-mediated immune escape in the malignant kidney tumour microenvironment
Yongbo Yu et al.
CELL DEATH DISCOVERY (2021)
Programmed cell death 1 ligand (PD-L1) on T cells generates Treg suppression from memory
Alexandra Kazanova et al.
PLOS BIOLOGY (2021)
Novel Anti-Cytokine Strategies for Prevention and Treatment of Respiratory Allergic Diseases
Ekaterina O. Gubernatorova et al.
FRONTIERS IN IMMUNOLOGY (2021)
PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis
Rafael Bonamichi-Santos et al.
FRONTIERS IN IMMUNOLOGY (2021)
Contribution of Regulatory T Cell Methylation Modifications to the Pathogenesis of Allergic Airway Diseases
Jiani Li et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Role of IL-17 in atopy-A systematic review
Maja A. Hofmann et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2021)
The PD-1:PD-L1 axis in Inflammatory Arthritis
Mary Canavan et al.
BMC RHEUMATOLOGY (2021)
IQGAP1 restrains T-cell cosignaling mediated by OX40
Yuko Okuyama et al.
FASEB JOURNAL (2020)
The blockade of PD-1/PD-L1 pathway promotes the apoptosis of CD19+CD25+ Bregs and suppresses the secretion of IL-10 in patients with allergic rhinitis
Zhao Wang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)
Immune checkpoint inhibitor-related dermatologic adverse events
Amaris N. Geisler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Advances and novel developments in mechanisms of allergic inflammation
Xiaorui Han et al.
ALLERGY (2020)
PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
Doumet Georges Helou et al.
NATURE COMMUNICATIONS (2020)
PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade
Qi Peng et al.
NATURE COMMUNICATIONS (2020)
Mechanisms of allergen-specific immunotherapy and allergen tolerance
Umut C. Kucuksezer et al.
ALLERGOLOGY INTERNATIONAL (2020)
Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy
Tonje Reier-Nilsen et al.
ALLERGY (2019)
The 2016 Melbourne thunderstorm asthma epidemic: Risk factors for severe attacks requiring hospital admission
Mark Hew et al.
ALLERGY (2019)
Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Merin E. Kuruvilla et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
Ioana Agache et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Long-term outcomes after sustained unresponsiveness in patients who underwent oral immunotherapy for egg, cow's milk, or wheat allergy
Tetsuharu Manabe et al.
ALLERGOLOGY INTERNATIONAL (2019)
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
Ana Bocanegra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma
Ali Mosayebian et al.
Iranian Journal of Allergy Asthma and Immunology (2019)
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy
Miren Zuazo et al.
EMBO MOLECULAR MEDICINE (2019)
Role of Biologics in Asthma
Mary Clare McGregor et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Mouse models of severe asthma for evaluation of therapeutic cytokine targeting
Ekaterina O. Gubernatorova et al.
IMMUNOLOGY LETTERS (2019)
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management
Emily Coleman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Regulatory T cells with superior immunosuppressive capacity emigrate from the inflamed colon to draining lymph nodes
Y. Nakanishi et al.
MUCOSAL IMMUNOLOGY (2018)
Mechanisms of Oral Tolerance
Leticia Tordesillas et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Correlation of PD-1/PD-L1 Signaling Pathway with Treg/Th17 Imbalance from Asthmatic Children
Xia Xi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2018)
Role of PD-1 during effector CD8 T cell differentiation
Eunseon Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa
Wei Wang et al.
JOURNAL OF IMMUNOLOGY (2018)
Regulatory T cells and asthma
Sheng-tao Zhao et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2018)
The intracellular signalosome of PD-L1 in cancer cells
David Escors et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Dermatologic Reactions to Immune Checkpoint Inhibitors Skin Toxicities and Immunotherapy
Vincent Sibaud
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells
Oscar Palomares et al.
IMMUNOLOGICAL REVIEWS (2017)
Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy
Karina L. Vivar et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Maria Gato-Canas et al.
CELL REPORTS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients
Rasoul Nasiri Kalmarzi et al.
ALLERGOLOGY INTERNATIONAL (2017)
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I. Puzanov et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Differential regulation of PD-1 and its ligands in allergic asthma
K. Bratke et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Programmed cell death-1 expression correlates with disease severity and IL-5 in chronic rhinosinusitis with nasal polyps
I. Kortekaas Krohn et al.
ALLERGY (2017)
Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma
Y. Kato et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma
Natsuko Matsumura et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
Vincent Sibaud et al.
CURRENT OPINION IN ONCOLOGY (2016)
Molecular and cellular mechanisms of food allergy and food tolerance
R. Sharon Chinthrajah et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy
Kurt B. Schaberg et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine
Kwang Soon Kim et al.
SCIENCE (2016)
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
Camille Hua et al.
JAMA DERMATOLOGY (2016)
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1
Jarushka Naidoo et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Food allergy: immune mechanisms, diagnosis and immunotherapy
Wong Yu et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside
Ioana Agache et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2015)
Suppression of antigen presentation by IL-10
Sharad K. Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Differential control of CD4+ T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma
Jaclyn W. McAlees et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Clinical blockade of PD1 and LAG3-potential mechanisms of action
Linh T. Nguyen et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Immediate-type hypersensitivity drug reactions
Shelley F. Stone et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma
C. Shen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Food allergy: Insights into etiology, prevention, and treatment provided by murine models
Michiko K. Oyoshi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens
Muebeccel Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
International consensus on (ICON) anaphylaxis
F. Estelle R. Simons et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2014)
Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis
Lisa M. Bartnikas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Basophils and allergic inflammation
Mark C. Siracusa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
The risk of rash associated with ipilimumab in patients with cancer: A systematic review of the literature and meta-analysis
Kira Minkis et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production
I. P. Lewkowich et al.
MUCOSAL IMMUNOLOGY (2013)
Strength of PD-1 signaling differentially affects T-cell effector functions
Fang Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
B and T lymphocyte attenuator regulates the development of antigen-induced experimental conjunctivitis
Waka Ishida et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Mucosal immunology of tolerance and allergy in the gastrointestinal tract
Lauren Steele et al.
IMMUNOLOGIC RESEARCH (2012)
Imaging mass spectrometry in biomarker discovery and validation
Kristina Schwamborn
JOURNAL OF PROTEOMICS (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
Role of PD-L1 and PD-L2 in allergic diseases and asthma
A. K. Singh et al.
ALLERGY (2011)
Cytokine/anti-cytokine therapy - novel treatments for asthma?
Philip M. Hansbro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells
Katarzyna Karwacz et al.
EMBO MOLECULAR MEDICINE (2011)
Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria
Usriansyah Hadis et al.
IMMUNITY (2011)
The immunological synapse: a cause or consequence of T-cell receptor triggering?
Balbino Alarcon et al.
IMMUNOLOGY (2011)
Programmed Death-1 Antibody Blocks Therapeutic Effects of T-Regulatory Cells in Cockroach Antigen-Induced Allergic Asthma
Halvor S. McGee et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance
Tomohiro Fukaya et al.
BLOOD (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
Marguerite Ghiotto et al.
INTERNATIONAL IMMUNOLOGY (2010)
PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions
O. Akbari et al.
MUCOSAL IMMUNOLOGY (2010)
The Immunological Synapse, TCR Microclusters, and T Cell Activation
Tadashi Yokosuka et al.
IMMUNOLOGICAL SYNAPSE (2010)
Infection rate and virus-induced cytokine secretion in experimental rhinovirus infection in mucosal organ culture - Comparison between specimens from patients with chronic rhinosinusitis with nasal polyps and those from normal subjects
Jong Hwan Wang et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2008)
The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
Audrey L. Kinter et al.
JOURNAL OF IMMUNOLOGY (2008)
Patient Perceptions of Allergic Rhinitis and Quality of Life Findings From a Survey Conducted in Europe and the United States
G. Walter Canonica et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2008)
Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4+ and CD8+ T cells In vivo
A. Habicht et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
Manish J. Butte et al.
IMMUNITY (2007)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Arlene H. Sharpe et al.
NATURE IMMUNOLOGY (2007)
Regulatory T cells as potential immunotherapy in allergy
Kajsa Wing et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Constantinos Petrovas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice
A. Fukushima et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
T-cell tolerance or function is determined by combinatorial costimulatory signals
Roza Nurieva et al.
EMBO JOURNAL (2006)
Mast cells enhance T cell activation: Importance of mast cell costimulatory molecules and secreted TNF
S Nakae et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibition of the allergic response by regulatory T cells
P Stock et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
B7-DC regulates asthmatic response by an IFN-γ-dependent mechanism
K Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2004)
Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo
E Oflazoglu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
M Akdis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation
B Dubois et al.
BLOOD (2003)
Ag-specific recognitiong activationg and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis
A Fukushima et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
P Loke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression of programmed death 1 ligands by murine T cells and APC
T Yamazaki et al.
JOURNAL OF IMMUNOLOGY (2002)
Exertion of the suppressive effects of IFN-γ on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase
A Fukushima et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Share Paper
